Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 33

Results: 14

Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4872, doi. 10.1038/sj.onc.1210265

By:

Qian, J.;
Steigerwald, K.;
Combs, K. A.;
Barton, M. C.;
Groden, J.

Publication type:

Article

Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4877, doi. 10.1038/sj.onc.1210266

By:

Tsang, W. P.;
Kwok, T. T.

Publication type:

Article

Ras effector pathways modulate scatter factor-stimulated NF-κB signaling and protection against DNA damage.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4774, doi. 10.1038/sj.onc.1210271

By:

Fan, S.;
Meng, Q.;
Laterra, J. J.;
Rosen, E. M.

Publication type:

Article

Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4850, doi. 10.1038/sj.onc.1210272

By:

Schniewind, B.;
Groth, S.;
Sebens Müerköster, S.;
Sipos, B.;
Schäfer, H.;
Kalthoff, H.;
Fändrich, F.;
Ungefroren, H.

Publication type:

Article

Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4817, doi. 10.1038/sj.onc.1210273

By:

Chen, M.;
Rahman, L.;
Voeller, D.;
Kastanos, E.;
Yang, S. X.;
Feigenbaum, L.;
Allegra, C.;
Kaye, F. J.;
Steeg, P.;
Zajac-Kaye, M.

Publication type:

Article

Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4882, doi. 10.1038/sj.onc.1210274

By:

Murayama, K.;
Kimura, T.;
Tarutani, M.;
Tomooka, M.;
Hayashi, R.;
Okabe, M.;
Nishida, K.;
Itami, S.;
Katayama, I.;
Nakano, T.

Publication type:

Article

Adenoviral E1B55K oncoprotein sequesters candidate leukemia suppressor sequence-specific single-stranded DNA-binding protein 2 into aggresomes.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4797, doi. 10.1038/sj.onc.1210281

By:

Fleisig, H. B.;
Orazio, N. I.;
Liang, H.;
Tyler, A. F.;
Adams, H. P.;
Weitzman, M. D.;
Nagarajan, L.

Publication type:

Article

HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4825, doi. 10.1038/sj.onc.1210282

By:

Singh, M. K.;
Nicolas, E.;
Gherraby, W.;
Dadke, D.;
Lessin, S.;
Golemis, E. A.

Publication type:

Article

Dose–response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21<sup>WAF1/CIP1</sup> in response to the novel anticancer agent, aminoflavone (NSC 686288).

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4806, doi. 10.1038/sj.onc.1210283

By:

Meng, L.-h.;
Kohn, K. W.;
Pommier, Y.

Publication type:

Article

Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4761, doi. 10.1038/sj.onc.1210284

By:

Wu, Y.-H.;
Tsai Chang, J.-H.;
Cheng, Y.-W.;
Wu, T.-C.;
Chen, C.-Y.;
Lee, H.

Publication type:

Article

JunB is a gatekeeper for B-lymphoid leukemia.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4863, doi. 10.1038/sj.onc.1210285

By:

Ott, R. G.;
Simma, O.;
Kollmann, K.;
Weisz, E.;
Zebedin, E. M.;
Schorpp-Kistner, M.;
Heller, G.;
Zöchbauer, S.;
Wagner, E. F.;
Freissmuth, M.;
Sexl, V.

Publication type:

Article

Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4833, doi. 10.1038/sj.onc.1210286

By:

Rigby, R. J.;
Simmons, J. G.;
Greenhalgh, C. J.;
Alexander, W. S.;
Lund, P K

Publication type:

Article

GRIM-19 associates with the serine protease HtrA2 for promoting cell death.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4842, doi. 10.1038/sj.onc.1210287

By:

Ma, X.;
Kalakonda, S.;
Srinivasula, S. M.;
Reddy, S. P.;
Platanias, L. C.;
Kalvakolanu, D. V.

Publication type:

Article

Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.

Published in:

Oncogene, 2007, v. 26, n. 33, p. 4749, doi. 10.1038/sj.onc.1210289

By:

Igarashi, T.;
Izumi, H.;
Uchiumi, T.;
Nishio, K.;
Arao, T.;
Tanabe, M.;
Uramoto, H.;
Sugio, K.;
Yasumoto, K.;
Sasaguri, Y.;
Wang, K. Y.;
Otsuji, Y.;
Kohno, K.

Publication type:

Article